- Savient Pharmaceuticals, Inc. Announces Results of
Annual Meeting of Stockholders.
EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) a specialty pharmaceutical company engaged in developing, manufacturing, and marketing pharmaceutical products that address unmet medical ......
- Savient Pharmaceuticals, Inc. Announces Results of
2005 Annual Meeting of Stockholders.
EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) an emerging specialty pharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet ......
- UBS Hosts Global Pharmaceuticals
Conference.
NEW YORK -- UBS (NYSE:UBS): WHAT: The UBS Global Pharmaceuticals Conference will feature presentations by over 90 pharmaceutical companies from 14 different countries. The ......
- KILL BW1061, NJ-HOFFMANN-LA-ROCHE.
Please KILL BW1061, (NJ-HOFFMANN-LA-ROCHE) Roche to Help Health Care Plans, Providers and Payers Better Evaluate Total Disease Cost, which ran on Business Wire at 7:04 ......
- From Atlanta, With Pharma Jobs
Pharmasset, which specializes in discovery and development of antiviral drugs, last week moved its headquarters from Atlanta to Princeton. The company says the availability of ......
- GIVING A LITTLE SOMETHING BACK
Irwin Lerner is one of the most illustrious graduates of the Rutgers Business School. Lerner did his undergraduate work on the Newark campus, graduating with ......
- A two-fer for Roche
Roche, the Swiss pharmaceutical giant, scored on two fronts last week. Genentech, the biotech company in which it owns a 60% interest, reported positive results ......
- Amgen and Hoffmann-La Roche extend Europeancollaboration.
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--April 14, 1997--Amgen (NASDAQ:AMGN) Monday announced that it has entered into an agreement with F. Hoffmann-La Roche Ltd. under which Amgen and ......
- Hoffmann-La Roche chief executive officer elected to board.
LA JOLLA, Calif.--(BUSINESS WIRE)--Jan. 30, 1996--The California Health Care Institute (CHI), a public policy research and advocacy organization representing leading California academic medical research institutions, ......
- Hoffmann-La Roche obtains United States
patent.
Hoffmann-La Roche Inc. (Nutley, NJ) has patented a novel cytokine protein called IL-12 or Cytotoxic Lymphocyte Maturation Factor (CLMF) produced and synthesized by human NC-37 ......
- Hoffmann-La Roche Offers California Law Enforcement Testing Capability in Fight Against...
NUTLEY, N.J.--(BUSINESS WIRE)--June 25, 1996--Hoffmann-La Roche Inc. announced today the availability in California of a drug testing service that will help the law enforcement community ......
- Applera takes action against F. Hoffmann-La
Roche.
Norwalk, CT 10/12/03--Applera announced that it has filed a compliant against F. Hoffman-La Roche in California Superior Court and a notice of arbitration with the ......
- Durham pharmaceutical.
Two small Durham pharmaceutical companies have asked the U.S. Food and Drug Administration to approve new AIDS drugs. Trimeris, working with New Jersey-based Hoffmann-La Roche, ......
- TSB TO MANAGE VOICE COMMUNICATIONS FOR HOFFMANN-LA ROCHE LIMITED.
TORONTO, ONTARIO--(BUSINESS WIRE)--JULY 7, 1995--TSB INTERNATIONAL INC. (TSE:TSB) TSB International Inc. has been awarded a three-year contract by Hoffmann-La Roche Limited to manage voice communications ......
- IGEN rests dase against Roche.
IGEN International, Inc. (Gaithersburg, MD; 301-869-9800) announced that it has concluded its presentation to the jury in its multi-count lawsuit against Roche Diagnostics, a division ......